Vascular occlusions in COVID-19: a case series

Authors: Vojtěch Mezera 1;  Anicet Mahumon Ulrich Kanhounnon 2
Authors‘ workplace: Geriatrické centrum, Pardubická nemocnice 1;  Kardiologické oddělení, Pardubická nemocnice 2
Published in: Geriatrie a Gerontologie 2021, 10, č. 4: 233-236


COVID-19 is associated with a high risk of venous thromboembolism. In addition, cases of arterial thromboembolism were also reported. Here, we report three different patients developing arterial and venous thromboses during COVID-19. Interestingly, the most hidden thrombosis was the only one with a good outcome.


COVID-19 – acute limb ischemia – deep venous thrombosis – arterial occlusion


1.  Klok FA, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191: 145–147.

2.  Chen T, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368: 1091.

3.  Violi F, Pastori D, Cangemi R, et al. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost 2020; 120(6): 949–956.

4.  Diaz JV. Clinical management of COVID-19: interim guidance. World Health Organization 2020. May, 1–62.

5.  Paranjpe I, et al. Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19. J Am Coll Cardiol 2020; 76(1): 122–124.

6.  Escalard S, et al. Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19: Experience From Paris. Stroke 2020; 51(8): 2540–2543.

7.  Song WC, FitzGerald GA. COVID-19, microangiopathy, hemostatic activation, and complement. J Clin Invest 2020; 130(8): 3950–3953.

8.  Zuo Y, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med 2020; 12(570): 3876.

9.  El Shamy O, et al. Bilateral Renal Artery Thrombosis in a Patient With COVID-19. Kidney Med 2021; 3: 116–119.

10.  Zhang L, et al. D-dimer levels on admission to predict in-hospital mortality in patients with COVID-19. J Thromb Haemost 2020; 18(6): 1324–1329.

11.  Maldonado E, et al. Antithrombotic Therapies in COVID-19 Disease: a systematic review. J Ger Intern Med 2020; 35(9): 2698–2706.

12.  Gupta N, et al. The stimulation of thrombosis by hypoxia. Thromb Res Sep 2019; 181: 77–83.

13.  Barbar S, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 2010; 8(11): 2450–2457.

14.  Česká společnost pro trombózu a hemostázu. Antitrombotická profylaxe u nemocných s COVID-19. Doporučený postup České společnosti pro trombózu a hemostázu ČLS JEP.

15.  Chow JH, et al. Aspirin Use is Associated with Decreased Mechanical Ventilation, ICU Admission, and In-Hospital Mortality in Hospitalized Patients with COVID-19. Anesth Analg; 2021 Apr 1;132(4):930–941.

16.  Česká společnost pro trombózu a hemostázu. Stanovisko výboru ČSTH k problematice očkování proti infekci COVID-19 očkovací látkou firmy AstraZeneca. Antitrombotická profylaxe u nemocných s COVID-19. (2021).

Geriatrics General practitioner for adults Orthopaedic prosthetics
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account